Source: Thrombosis Research. Unidade: FM
Subjects: POLIMORFISMO, TROMBOSE, NEOPLASIAS (GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMACCIOTTI, Eduardo et al. Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis. Thrombosis Research, v. 109, p. 171-174, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0049-3848(03)00179-8. Acesso em: 13 set. 2024.APA
Ramacciotti, E., Wolosker, N., Puech-Leao, P., Zeratti, E. A., Gusson, P. R., Giglio, A. del, & Franco, R. F. (2003). Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis. Thrombosis Research, 109, 171-174. doi:10.1016/s0049-3848(03)00179-8NLM
Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, Giglio A del, Franco RF. Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis [Internet]. Thrombosis Research. 2003 ; 109 171-174.[citado 2024 set. 13 ] Available from: https://doi.org/10.1016/s0049-3848(03)00179-8Vancouver
Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, Giglio A del, Franco RF. Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorfism in cancer patients with and without venous thrombosis [Internet]. Thrombosis Research. 2003 ; 109 171-174.[citado 2024 set. 13 ] Available from: https://doi.org/10.1016/s0049-3848(03)00179-8
